Penetration of anticancer drugs through solid tissue: A factor that limits the effectiveness of chemotherapy for solid tumors

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1583-1586

  Tunggal, Jonathan K ^a   Cowan, David S M ^a   Shaikh, Hafsa ^a   Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; POLITEF;

ANIMAL CELL; ARTICLE; ARTIFICIAL MEMBRANE; BREAST CARCINOMA; BREAST SARCOMA; CARCINOMA CELL; CELL MEMBRANE TRANSPORT; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG PENETRATION; DRUG UPTAKE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TRANSPORT KINETICS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; DOXORUBICIN; FLUOROURACIL; HUMANS; METHOTREXATE; MICE; MITOXANTRONE; NEOPLASMS, EXPERIMENTAL; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032978250     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tannock I. F., and Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res., 49: 4373-4384, 1989.
2. Jain, R. K. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev., 9: 253-266, 1990.
3. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen, and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
4. Vukovic, V., and Tannock, I. F. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Br. J. Cancer, 75: 1167-1172, 1997.
5. Kerr, D. J., and Kaye, S. B. Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother. Pharmacol., 19: 1-5, 1987.
6. Nederman, T., Carlsson J., and Malmquist, M. Penetration of substances into tumour tissue. A methodological study on cellular spheroids. In Vitro, 17: 290-298, 1981.
7. Durand, R. E. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res., 41: 3495-3498, 1981.
8. Durand, R. E. Distribution and activity of antineoplastic drugs in a tumor model. J. Natl. Cancer Inst., 81: 146-152, 1989.
9. Durand R. E. Use of Hoechst 33342 for cell selection from multicell system. J. Histochem. Cytochem., 30: 117-122, 1982.
10. Olive, P. L., Chaplin D. J., and Durand, R. E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br. J. Cancer, 52: 739-746, 1985.
11. Cowan, D. S. M., Hicks, K. O., and Wilson, W. R. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br. J. Cancer. 74 (Suppl. xxvii): 528s-531s, 1996.
12. Hicks, K. O., Ohms. S. J., van Zijl. P. L., Denny, W. A., Hunter, P. J., and Wilson, W. R. An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br. J. Cancer, 76: 894-903, 1997.
13. Nicholson, K. M., Bibby, M. C., and Phillips, R. M. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Eur. J. Cancer, 33: 1291-1298, 1997.
14. Tannock, I. F. Conventional cancer therapy: promise broken or promise delayed? Lancet, 351 (Suppl. II): 1s-29s, 1998.
15. Hait, W. N. Drug Resistance, pp. 198-201. Boston, MA: Kluwer Academic Publishers, 1996.